Biodelivery Sciences International Inc (BDSI) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Biodelivery Sciences International Inc   (NASDAQ: BDSI)


Biodelivery Sciences International Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biodelivery Sciences International Inc's ROI in the fourth quarter of 2021?
Biodelivery Sciences International Inc achieved a return on average invested assets (ROI) of 42.72 % in its fourth quarter of 2021 a new company high.

ROI has improved compared to 16.86% in the third quarter of 2021, due to net income growth.

Within the Healthcare sector 31 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2021 quarter, so far to 136, from total ROI ranking in the third quarter of 2021 at 369.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM 20.29 % 21.61 % 31.22 % 36.39 % 39.71 %
Y / Y Net Income Change TTM 230.05 % 110.33 % 523.39 % 508.48 % -
Investment (TTM) in Millions 242 178 186 188 187
Return On Investment (TTM) 42.72 % 16.86 % 18.43 % 14.59 % 15.57 %
BDSI's Overall Ranking # 136 # 369 # 270 # 240 # 189
Seq. Investment Change TTM 7.48 % 0.53 % 3.23 % 7.85 % 8.66 %
Seq. Net Income Change TTM 172.28 % -8.01 % 30.4 % 1.05 % 73.51 %
Net Income (TTM) in Millions 85 31 34 26 26

BDSI Company Profile >> Back to BDSI Roi Comparisons >> See Annual BDSI Return On Investment



Return On Investment BDSI's Ranking
Within: No.
Industry # 16
Sector # 32
Overall # 136

Return On Investment Statistics
High Average Low
42.72 %
-57.6 %
-274.09 %
(Dec 31 2021)   (Dec. 30, 2013)







Financial Statements
Biodelivery Sciences International Inc's IV. Quarter Investments $ 242 Millions BDSI's Balance sheet
Biodelivery Sciences International Inc's IV. Quarter Income $ 64 Millions Quarterly BDSI's Income Statement
BDSI's Income by Division See BDSI's Income by Division


BDSI Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 242 187 129 87 62
Y / Y Investment Growth 29.6 % 44.98 % 48.18 % 40.42 % 91.02 %
Net Income in Millions 85 26 -15 -34 5
Y / Y Net Income Growth 230.05 % - - - -
Annual Return On Investment 35.03 % 13.76 % -11.87 % -38.93 % 8.53 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 35.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BDSI's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BDSI's Competitors
Subscribers only: Roi for Biodelivery Sciences International Inc's Suppliers
Subscribers only: Return On Investment for BDSI's Customers

Other Ratios
BDSI's Roa BDSI's Inventory Turnover Ratio BDSI's Growth Rates BDSI's Dividend Statistics
BDSI's Profitability Ratios BDSI's Asset Turnover Ratio BDSI's Dividend Growth
BDSI's Roe BDSI's Valuation Ratios BDSI's Financial Strength Ratios BDSI's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Omeros Corporation  117.05 %
Galmed Pharmaceuticals Ltd   105.45 %
Sinovac Biotech Ltd  93.85 %
Vyne Therapeutics Inc   93.73 %
Agios Pharmaceuticals Inc   90.82 %
Biontech Se  84.02 %
Vivos Therapeutics Inc   72.72 %
Ovid Therapeutics Inc   59.58 %
Carisma Therapeutics Inc   58.59 %
Glucotrack Inc   58.06 %
Biomx Inc  57.30 %
Ironwood Pharmaceuticals inc   55.38 %
Iteos Therapeutics Inc   54.32 %
Reflect Scientific Inc  52.07 %
Fulgent Genetics Inc   50.82 %
Silo Pharma Inc  50.34 %
Siga Technologies Inc  49.80 %
Uniqure N v   49.63 %
Vir Biotechnology Inc   49.45 %
Molecular Templates Inc   48.02 %
Biocept Inc   47.39 %
Integrated Biopharma Inc  46.85 %
Retractable Technologies Inc  46.68 %
Regeneron Pharmaceuticals Inc   43.91 %
Biodelivery Sciences International Inc   42.72 %
Idexx Laboratories Inc  41.83 %
Semler Scientific inc   41.56 %
Inmode Ltd   38.69 %
Quidelortho Corp  37.03 %
Innoviva Inc   36.64 %

Date modified: 2026-09-08T15:10:31+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.